{
    "medicine_id": "459a702810ba156958e06d7d7de8c6641f0bf928",
    "platform_id": "DB11386",
    "metadata": {
        "name": "Aurisan Dps 0 5 g 100g Ointment",
        "composition": "0 5 g 100g Chlorobutanol",
        "clinical_particulars": {
            "therapeutic_indications": "No approved therapeutic indications on its own",
            "contraindications": {
                "disease": "Oral LD50 of anhydrous chlorobutanol in rat is 510 mg kg MSDS Chlorobutanol was shown to induce conjunctival and corneal cell toxicity _in vitro_",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Chlorobutanol is a detergent preservative with a broad spectrum of antimicrobial activity A32744 _In vitro_ chlorobutanol demonstrated to inhibit platelet aggregation and release via unknown mechanisms A32739 A study proposes that the antiplatelet effect of chlorobutanol may occur from inhibition of the arachidonic acid pathway A32739 It attenuated thromboxane B2 formation elevation of cytosolic free calcium and ATP release and additionally exhibited a significant inhibitory activity toward several aggregation inducers in a time and concentration dependent manner A32739 Chlorobutanol may exert a direct negative inotropic effect on myocardial cells to isometric tension produced by the heart A32740 Chlorobutanol was shown to induce conjunctival and corneal cell toxicity _in vitro_ at a concentration of 0 1 Cbl caused near depletion of the squamous layer while degeneration of corneal epithelial cells generation of conspicuous membranous blebs cytoplasmic swelling and occasional breaks in the external cell membrane were observed at a concentration of 0 5 A32744",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}